The Jikei University Hospital
Tokyo, Japan
Hospital in Minato, Tokyo
3 Chome-19-18 Nishishinbashi, Minato City, Tokyo 105-0003
About The Jikei University Hospital
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Shire
7
Pfizer
6
Takeda
5
Hoffmann-La Roche
4
Janssen Research & Development, LLC
4
Bristol-Myers Squibb
3
Galapagos NV
3
Haruhiko Fukuda
3
Translational Research Center for Medical Innovation, Kobe, Hyogo, Japan
3
Amicus Therapeutics
2
Associations for Establishment of Evidence in Interventions
2
Clinical Trials at The Jikei University Hospital
During the past decade, The Jikei University Hospital conducted 52 clinical trials. In the 10-year time frame, 52 clinical trials started and 39 clinical trials were completed, i.e. on
average, 75% percent of trials that started reached the finish line to date. In the past 5 years, 12 clinical trials started and 24 clinical trials were completed. i.e. 200%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Paclitaxel in Treating Patients With Ovarian Stromal Cancer
2000-11-20
2016-07-16
Completed
31
Doxorubicin Hydrochloride, Cisplatin, and Paclitaxel or Carboplatin and Paclitaxel in Treating Patients With Stage III-IV or Recurrent Endometrial Cancer
2003-08-25
2021-01-05
Completed
1,381
A Morbidity-Mortality and Remodeling Study With Valsartan
2002-01-01
2005-11-01
Unknown status
3,000
Trial to Evaluate Radiotherapy Followed by Endocrine Therapy Vs Endocrine Therapy Alone for PSA Failure After Radical Prostatectomy
2004-05-01
2016-05-01
Completed
200
Rituximab+Standard CHOP vs Rituximab+Bi-weekly CHOP for Untreated Stage III/IV Low-grade B-cell Lymphoma (JCOG0203)
2002-09-01
2010-02-01
Completed
300
Phase III Study of Docetaxel + S-1 vs. S-1 for Advanced Gastric Cancer
2006-03-01
2010-10-01
Completed
628
Trial of TP Versus TC Regimens for Stage IVb, Persistent, or Recurrent Cervical Cancer (JCOG0505, CC-TPTC-P3)
2006-02-01
2011-11-01
Completed
253
Tegafur-Uracil or Observation in Treating Patients With Stage II Colorectal Cancer That Has Been Completely Removed By Surgery
2006-10-01
2016-09-01
Completed
2,025
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "The Jikei University Hospital" #1 sponsor was "Shire" with 7 trials, followed by "Pfizer" with 6 trials
sponsored, "Takeda" with 5 trials sponsored, "Hoffmann-La Roche" with 4 trials sponsored and "Janssen Research & Development, LLC"
with 4 trials sponsored. Other sponsors include 57 different institutions and
companies that sponsored additional 48 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "The Jikei University Hospital"
#1 collaborator was "Gilead Sciences" with 3 trials as a collaborator, "Ministry of Health, Labour and Welfare, Japan" with 3 trials as a collaborator, "National Cancer Institute (NCI)" with 3 trials as a collaborator, "Japan Lung Cancer Society" with 2 trials as a collaborator and "NRG Oncology" with 2 trials as a collaborator. Other collaborators include 17 different institutions and companies that were
collaborators in the rest 27 trials.
Clinical Trials Conditions at The Jikei University Hospital
According to Clinical.Site data, the most researched conditions in "The Jikei University Hospital" are
"Crohn's Disease" (10 trials), "Ulcerative Colitis" (9 trials), "Ovarian Cancer" (5 trials), "Fallopian Tube Cancer" (4 trials) and "Prostate Cancer" (4 trials). Many other conditions were trialed in "The Jikei University Hospital" in a lesser frequency.
Clinical Trials Intervention Types at The Jikei University Hospital
Most popular intervention types in "The Jikei University Hospital" are "Drug" (64 trials), "Device" (13 trials), "Other" (13 trials), "Biological" (9 trials) and "Procedure" (3 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (19 trials), "Paclitaxel" (5 trials), "Carboplatin" (4 trials), "Filgotinib" (4 trials) and "Guselkumab" (4 trials). Other intervention names were less common.
Clinical Trials Genders at The Jikei University Hospital
The vast majority of trials in "The Jikei University Hospital" are
68 trials for "All" genders, 14 trials for "Female" genders and 6 trials for "Male" genders.
Clinical Trials Status at The Jikei University Hospital
Currently, there are NaN active trials in "The Jikei University Hospital".
undefined are not yet recruiting,
10 are recruiting,
18 are Active, not recruiting,
and 1 are Enrolling by invitation.
In total, there were 51 completed trials in The Jikei University Hospital,
undefined suspended trials,
and 7 terminated clinical trials to date.
Out of the total trials that were conducted in The Jikei University Hospital, 2 "Phase 1"
clinical trials were conducted, 16 "Phase 2" clinical
trials and 50 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 4 trials, and there were
also 12 trials that are defined as “Not Applicable".